Cargando…
Lofexidine for acute opioid withdrawal: A clinical case series
INTRODUCTION: Maintaining abstinence through the opioid withdrawal period is a substantial barrier to treatment for patients with opioid use disorder. The alpha-2 agonist lofexidine has demonstrated efficacy and safety in clinical trials, but pragmatic studies describing its use in clinical practice...
Autores principales: | Renfro, Mandy L., Loera, Lindsey J., Tirado, Carlos F., Hill, Lucas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
College of Psychiatric & Neurologic Pharmacists
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534813/ https://www.ncbi.nlm.nih.gov/pubmed/33062550 http://dx.doi.org/10.9740/mhc.2020.09.259 |
Ejemplares similares
-
The Role of Lofexidine in Management of Opioid Withdrawal
por: Pergolizzi, Joseph V., et al.
Publicado: (2018) -
Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial
por: Fishman, Marc, et al.
Publicado: (2019) -
Managing Opioid Withdrawal in an Outpatient Setting With Lofexidine or Clonidine
por: Gripshover, Jeanne, et al.
Publicado: (2022) -
Efficacy of lofexidine for mitigating opioid withdrawal symptoms: results from two randomized, placebo-controlled trials
por: Alam, Danesh, et al.
Publicado: (2020) -
Lofexidine for Treating Opioid Withdrawal Syndrome in Palliative Care Patients
por: Nair, Abhijit S
Publicado: (2018)